Milan Majkic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Milan Majkic has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Boris Obrovski
University of Novi Sad
1 shared publication - Branko Baljak
Clinic for Orthopedic Surgery and Traumatology, Clinical Center of Vojvodina, 21000 Novi Sad, Serbia
1 shared publication - Jasmina Grujic
Department of Transfusiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia
1 shared publication - Milan Milinkov
University of Novi Sad, University Clinical Center of Vojvodina
1 shared publication - Milan Tošić
Clinic for Orthopedic Surgery and Traumatology, Clinical Center of Vojvodina, 21000 Novi Sad, Serbia
1 shared publication - Milomir Radoslav Bezanovic
Blood Transfusion Institute of Vojvodina, Novi Sad, Serbia
1 shared publication
Latest Publications
- 1 April 2024
- Published by Wiley in Transfusion Medicine
- Vol. 34 (3) , 200-210
Reactivity of anti‐SARS‐CoV‐2 antibodies in Serbian voluntary blood donors
Background: The COVID‐19 pandemic has major implications on the entire blood supply system worldwide. Seroepidemiological studies are certainly necessary for better understanding the global burden that the COVID‐19 pandemic represents.Objectives: In this study, we analysed the association between demographic factors, COVID‐19 severity, vaccination status and the reactivity of anti‐SARS‐CoV‐2 IgG antibodies in Serbian blood donors.Materials and Methods: In a prospective study, demographic data and data related to previous SARS‐CoV‐2 infection, COVID‐19 severity and vaccination status among whole blood donors were analysed, from February 10 to August 10, 2022, at the Blood Transfusion Institute of Vojvodina, Serbia. The detection and determination of the level of anti‐SARS‐CoV‐2 IgG antibodies were performed using LIAISON® SARS‐CoV‐2 TrimericS IgG immunoassay.Results: A total of 1190 blood donors were included, 24.5% were female and 75.5% were male while their average age was 41 years. Anti‐SARS‐CoV‐2 antibody values ranged from 2.40 to 3120 BAU/ml with a mean value of 1354.56 BAU/ml. Statistical analysis showed that COVID‐19 severity and vaccination status are linked with reactivity of anti‐SARS‐CoV‐2 antibodies, while gender and age of voluntary blood donors are not related to the values of anti‐SARS‐CoV‐2 antibodies.Conclusion: The values of anti‐SARS‐CoV‐2 antibodies in voluntary blood donors in Serbia are kept relatively high, especially in blood donors who have overcome the severe COVID‐19, as well as in donors who have been vaccinated against COVID‐19. Further SARS‐CoV‐2 seroprevalence studies in our country are certainly still necessary so global strategies to fight against COVID‐19 would be adequately evaluated.
- 1 April 2024
- Published by Wiley in Transfusion Medicine
- Vol. 34 (3) , 200-210
Reactivity of anti‐SARS‐CoV‐2 antibodies in Serbian voluntary blood donors
Background: The COVID‐19 pandemic has major implications on the entire blood supply system worldwide. Seroepidemiological studies are certainly necessary for better understanding the global burden that the COVID‐19 pandemic represents.Objectives: In this study, we analysed the association between demographic factors, COVID‐19 severity, vaccination status and the reactivity of anti‐SARS‐CoV‐2 IgG antibodies in Serbian blood donors.Materials and Methods: In a prospective study, demographic data and data related to previous SARS‐CoV‐2 infection, COVID‐19 severity and vaccination status among whole blood donors were analysed, from February 10 to August 10, 2022, at the Blood Transfusion Institute of Vojvodina, Serbia. The detection and determination of the level of anti‐SARS‐CoV‐2 IgG antibodies were performed using LIAISON® SARS‐CoV‐2 TrimericS IgG immunoassay.Results: A total of 1190 blood donors were included, 24.5% were female and 75.5% were male while their average age was 41 years. Anti‐SARS‐CoV‐2 antibody values ranged from 2.40 to 3120 BAU/ml with a mean value of 1354.56 BAU/ml. Statistical analysis showed that COVID‐19 severity and vaccination status are linked with reactivity of anti‐SARS‐CoV‐2 antibodies, while gender and age of voluntary blood donors are not related to the values of anti‐SARS‐CoV‐2 antibodies.Conclusion: The values of anti‐SARS‐CoV‐2 antibodies in voluntary blood donors in Serbia are kept relatively high, especially in blood donors who have overcome the severe COVID‐19, as well as in donors who have been vaccinated against COVID‐19. Further SARS‐CoV‐2 seroprevalence studies in our country are certainly still necessary so global strategies to fight against COVID‐19 would be adequately evaluated.
- Open Access
Segmental Humeral Head Reconstruction in Patients with Chronic Locked Posterior Shoulder Dislocation
Background and Objectives: The goal of this study was to evaluate the functional outcomes of patient treatment using an allograft after chronic locked posterior shoulder dislocation associated with a bony defect of the upper edge of the humerus that involves 25–50% of the articular surfaces. Materials and Methods: A total of 20 patients were included in this study. Electrocution was the cause of injury in eight patients; in ten patients, the cause was direct trauma; and in two patients, the cause of injury was a fall due to hypoglycemic coma. A standard deltoid pectoral approach was used and a fresh-frozen osteochondral allograft of the femoral condyle was applied. In evaluating the results, Constant’s scoring scale was used. Results: The average value of Constant’s point scale for the operated shoulder is 84.14 points. This result is good according to the average value of Constant’s point scale. Conclusions: Patients with locked chronic posterior dislocation in combination with a bony defect of the humeral head that covers 25–50% of the articular surface, in our opinion, should be treated using bone allografts rather than non-anatomical reconstruction methods.
Open AccessSegmental Humeral Head Reconstruction in Patients with Chronic Locked Posterior Shoulder Dislocation
Background and Objectives: The goal of this study was to evaluate the functional outcomes of patient treatment using an allograft after chronic locked posterior shoulder dislocation associated with a bony defect of the upper edge of the humerus that involves 25–50% of the articular surfaces. Materials and Methods: A total of 20 patients were included in this study. Electrocution was the cause of injury in eight patients; in ten patients, the cause was direct trauma; and in two patients, the cause of injury was a fall due to hypoglycemic coma. A standard deltoid pectoral approach was used and a fresh-frozen osteochondral allograft of the femoral condyle was applied. In evaluating the results, Constant’s scoring scale was used. Results: The average value of Constant’s point scale for the operated shoulder is 84.14 points. This result is good according to the average value of Constant’s point scale. Conclusions: Patients with locked chronic posterior dislocation in combination with a bony defect of the humeral head that covers 25–50% of the articular surface, in our opinion, should be treated using bone allografts rather than non-anatomical reconstruction methods.